1. Danielson C, Benjamin RJ, Mangano MM, Mills CJ, Waxman DA. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration. Transfusion. 2008. 48:2401–2408.
Article
2. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004. 44:1774–1789.
Article
3. Middelburg RA, van Stein D, Briet E, van der Bom JG. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion. 2008. 48:2167–2176.
Article
4. Huh JY, Han TH, Seo JW, Kim DC, Roh DH, Han KS. A case of transfusion-related acute lung injury. Korean J Blood Transfus. 2005. 16:250–254.
5. Li G, Daniels CE, Kojicic M, Krpata T, Wilson GA, Winters JL, Moore SB, Gajic O. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion. 2009. 49:13–20.
Article
6. Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis. 1983. 128:185–189.
7. Cherry T, Steciuk M, Reddy VV, Marques MB. Transfusion-related acute lung injury: past, present, and future. Am J Clin Pathol. 2008. 129:287–297.
8. Fiebig EW, Wu AH, Krombach J, Tang J, Nguyen KA, Toy P. Transfusion-related acute lung injury and transfusion-associated circulatory overload: mutually exclusive or coexisting entities? Transfusion. 2007. 47:171–172.
Article
9. Win N, Massey E, Lucas G, Sage D, Brown C, Green A, Contreras M, Navarrete C. Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome. Hematology. 2007. 12:461–469.
Article
10. Win N, Chapman CE, Bowles KM, Green A, Bradley S, Edmondson D, Wallis JP. How much residual plasma may cause TRALI? Transfus Med. 2008. 18:276–280.
Article
11. Su L, Kamel H. How do we investigate and manage donors associated with a suspected case of transfusion-related acute lung injury. Transfusion. 2007. 47:1118–1124.
Article
12. Curtis BR, McFarland JG. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies. Crit Care Med. 2006. 34:5 Suppl. S118–S123.
Article
13. Steciuk M, Marques MB. A new "initial" case of transfusion-related acute lung injury. Blood. 2008. 111:5257–5258.
Article
14. Stroncek DF, Klein HG. Heavy breathing in the blood bank: is it transfusion-related acute lung injury, our anxiety, or both. Transfusion. 2007. 47:559–562.
Article
15. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol. 1996. 93:707–713.
Article
16. Nishimura M, Hashimoto S, Takanashi M, Okazaki H, Satake M, Nakajima K. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med. 2007. 17:129–134.
Article
17. Flesch BK, Neppert J. Transfusion-related acute lung injury caused by human leucocyte antigen class II antibody. Br J Haematol. 2002. 116:673–676.
Article
18. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003. 43:177–184.
Article
19. Sachs UJ. The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion. Transfus Apher Sci. 2007. 37:273–282.
Article
20. Cohen H, Taylor C, Mold D, Jones H. The 2008 Annual SHOT(Serious Hazards of Transfusion) Report. 2009. accessed on Nov. 15 2009. Available at
http:www.shot-uk.org.